Last reviewed · How we verify
Forest Pharmaceuticals Inc's Bystolic Tablets
At a glance
| Generic name | Forest Pharmaceuticals Inc's Bystolic Tablets |
|---|---|
| Sponsor | Torrent Pharmaceuticals Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet (PHASE1)
- Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: